Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 1 - 5 out of 328
Kandler, J, Kantarçeken, AS, Smajić, A & Ecker, GF 2026, 'Combined Modeling Approaches for Assessing Sodium-Iodide Symporter Inhibition', Journal of Chemical Information and Modeling, vol. 66, no. 3, pp. 1688-1703. https://doi.org/10.1021/acs.jcim.5c02855
Ćerimagić, T, Sosnin, S & Ecker, GF 2026, 'A multi-task learning approach for prediction of missing bioactivity values of compounds for the SLC transporter superfamily', Digital Discovery, vol. 5, no. 2, pp. 878-890. https://doi.org/10.1039/d5dd00536a
Grillberger, K, Magel, V, Leist, M & Ecker, GF 2026, 'Leveraging Consensus Docking Approaches for Human Mitochondrial Complexes I and III', Chemical Research in Toxicology, vol. 39, no. 1, pp. 79-94. https://doi.org/10.1021/acs.chemrestox.5c00348
Juhás, M & Ecker, G 2026, 'A Proteochemometric Model for Ligands of the SLC5 Transporter Family', Archiv der Pharmazie, vol. 359, no. 1, e70183, pp. 1-15. https://doi.org/10.1002/ardp.70183
Helmke, PS, Kandler, J, Ilie, S, Gaskin, L & Ecker, GF 2025, 'Data-driven assessment of bioisosteric replacements and their influence on off-target activity profiles', RSC Medicinal Chemistry, vol. 16, no. 12, pp. 6048-6058. https://doi.org/10.1039/d5md00686d
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding